卡纳比诺伊德高进化综合征 - - 一种基于调查的方法,以了解症状和大麻使用模式
Codi Peterson1, Jill Simonian2, Megan Mbengue3
1School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, Irvine, California, USA.
Cannabis and cannabinoid research
|March 5, 2026
概括
大麻素超症候群 (CHS) 与每天长期使用吸入大麻有关,特别是来自vape弹. 早晨的恶心和胃痛是关键的警告信号,女性会出现更严重的症状.
科学领域:
- 医学研究 医学研究
- 临床毒理学 临床毒理学
- 大麻研究研究大麻研究.
背景情况:
- 加拿大大麻使用者中的一些人经常吐,加拿大大麻使用者中的一些人经常吐,加拿大大麻使用者中的一些人经常吐.
- 缺乏早期识别工具阻碍了对CHS的及时干预.
- 了解CHS风险因素和警告标志对于减少危害和改善患者结果至关重要.
研究的目的:
- 调查与CHS相关的大麻使用模式.
- 确定CHS的症状概况和危险因素.
- 加强对CHS的早期识别和干预策略.
主要方法:
- 通过社交媒体分发了一项匿名在线调查,以收集有关大麻使用和CHS症状的自我报告数据.
- 参与者从专注于CHS的在线社区中招募.
主要成果:
- 在1134名参与者中,有45%的人报告每天使用大麻 (≥6次/天) 在症状开始时.
- 在65.4%的受访者中,长期使用 (≥3年) 先于CHS症状.
- 早晨恶心和胃痛是常见的前兆症状;女性报告了更严重的症状.
结论:
- CHS与频繁,长期使用吸入的delta-9-tetrahydrocannabinol (Δ9-THC) 主导大麻密切相关.
- 电子烟弹的使用与CHS症状的更快发作有关.
- 提高对这些使用模式的认识可以帮助更早地识别和管理CHS.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
866
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
866
Assessment of the Gastrointestinal System I: Subjective Data
753
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
753
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.0K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.0K
Assessment of the Gastrointestinal System II: Health Perception Pattern
544
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
544
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
698
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
698
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K


